| Benign | Malignant | ||
---|---|---|---|---|
No. | (%) | No. | (%) | |
No. | 24 | 40.7 | 35 | 59.3 |
Age, years | ||||
 <55 | 19 | 79.2 | 8 | 22.9 |
 ≥55 | 5 | 20.8 | 27 | 77.1 |
Tumor size | N/A | Â | Â | Â |
 pT1 (≤2 cm) |  |  | 28 | 80 |
 pT2 (2–5 cm) |  |  | 5 | 14.3 |
 pT3 (>5 cm) |  |  | 2 | 5.7 |
Lymph node status | N/A | Â | Â | Â |
 Negative |  |  | 29 | 85.3 |
 Positive |  |  | 5 | 14.7 |
Histological grade | N/A | Â | Â | Â |
 1 |  |  | 6 | 18.2 |
 2 |  |  | 18 | 54.5 |
 3 |  |  | 9 | 27.3 |
Estrogen receptor status | N/A | Â | Â | Â |
 Negative |  |  | 2 | 5.9 |
 Positive |  |  | 32 | 94.1 |
Progesterone receptor status | N/A | Â | Â | Â |
 Negative |  |  | 4 | 11.8 |
 Positive |  |  | 30 | 88.2 |
HER2 status | N/A | Â | Â | Â |
 0 |  |  | 5 | 15.2 |
 1+ |  |  | 22 | 66.7 |
 2+ |  |  | 5 | 15.2 |
 3+ |  |  | 1 | 3 |